Modulation of aflatoxin B1 activated protein kinase C by phenolic compounds

Cancer Letters

Volumn 121, Issue 1, 1997, Pages 99-104

  Mistry, K J ^a   Krishna, M ^a   Bhattacharya, R K ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Aflatoxin B1; Modulation; Phenolics; Protein kinase C

Indexed keywords

AFLATOXIN B1; CURCUMIN; ELLAGIC ACID; KAEMPFEROL; PHENOL DERIVATIVE; PROTEIN KINASE C; QUERCETIN; RUTOSIDE; DRUG DERIVATIVE; FLAVONOID; KAEMPFEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; LIVER CELL NUCLEUS; LIVER CYTOSOL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; CYTOSOL; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; WISTAR RAT;

AFLATOXIN B1; ANIMALS; CELL NUCLEUS; CURCUMIN; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; ENZYME ACTIVATION; FLAVONOIDS; KAEMPFEROLS; MALE; PHENOLS; PROTEIN KINASE C; QUERCETIN; RATS; RATS, WISTAR;

EID: 0030608643     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00337-6     Document Type: Article

References (50)

1. 1: role of non-nutrient phenolic compounds on the catalytic activity of liver fractions. In Vivo. 8:1994;1095-1098.
2. Berridge M.J. Rapid accumulation of inositol triphosphates reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem. J. 212:1983;849-858.
3. R.K. Bhattacharya, Flavonoids as modulators of carcinogenesis, in: N.P. Das (Ed.), Flavonoids in Biology and Medicine. III. Current Issues in Flavonoid Research, National University of Singapore, Singapore, 1990, pp. 339-347.
4. 1 leading to activation and DNA adduct formation. Cancer Lett. 39:1988;85-91.
5. R.K. Bhattacharya, P.F. Firozi, Interaction of polyphenols with microsomal monooxygenase during carcinogen activation, in: Groupé Polyphenol, Vol. 15, Proceedings of the Vth International Conference, Université Louis Pasteur, Strasbourg, 1990, pp. 179-184.
6. 1 in vitro. Carcinogenesis. 5:1984;1359-1362.
7. Chang R.L., Huang M.-T., Wood A.W., Wong C.-Q., Newmark H.L., Yagi H., Sayer J.M., Jerina D.M., Conney A.H. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)7β, 8a-dihydroxy-9a, 10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in newborn mouse. Carcinogenesis. 6:1985;1127-1133.
8. Choudhury S., Krishna M., Bhattacharya R.K. Phosphoinositide turnover during hepatocarcinogenesis induced by N-nitrosodiethylamine. Cancer Lett. 93:1995;213-218.
9. Creba J.A., Downes C.P., Hawkins P.T., Brewster G., Michell R.H., Kirk C.J. Rapid breakdown of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other calcium mobilizing hormones. Biochem. J. 212:1983;733-747.
10. Elangova V., Sekar N., Govindswamy S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene induced tumorigenesis. Cancer Lett. 87:1994;107-113.
11. 1 as detected in vitro in a simple fluorimetric assay. Chem.-Biol. Interact. 58:1986;173-186.
12. 1. Chem.-Biol. Interact. 100:1995;41-51.
13. 1 activation in a reconstituted microsomal monooxygenase system. J. Biochem. Toxicol. 10:1995;25-31.
14. 1: in vitro effect of plant flavonoids. Mutat. Res. 222:1989;393-401.
15. 1 and N-methyl-N′-nitro-N-nitrosoguanidine by certain phenolic compounds. Cancer Lett. 45:1989;177-182.
16. Gouldwell W.T., Ulm J.H., Antel I.P. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery. 29:1991;880-887.
17. 2+ dependent protein kinase in human colon carcinomas. Cancer Res. 47:1987;2036-2039.
18. Hannun Y.A., Bell R.M. Lysosphingolipids inhibits protein kinase C: implications for sphingolipidosis. Science. 235:1987;670-674.
19. Hannun Y.A., Loomis C.R., Bell R.M. Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J. Biol. Chem. 260:1985;10039-10040.
20. Herman K. Flavonols and flavones in food plants, a review. J. Food Technol. 11:1976;433-448.
21. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinoline sulfonamide, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochem. J. 23:1984;5036-5041.
22. Hunter T., Cooper J.A. Protein tyrosine kinases. Annu. Rev. Biochem. 54:1985;897-930.
23. Kreuter D., Caldwell A.B., Morin M.J. Dissociation of protein kinase C activation from phorbol ester induced maturation of HL-60 leukemia cells. J. Biol. Chem. 260:1985;5979-5984.
24. Lalwani N.D., Heylemon P.B., Strom S.C. Altered levels of phosphoinositide metabolites and activation of guanine nucleotide dependent phospholipase C in rat hepatic tumors. J. Cell Physiol. 147:1991;354-361.
25. Lesca P. Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene induced neoplasia in mice. Carcinogenesis. 4:1983;1651-1653.
26. Loomis C.R., Bell R.M. Sangivamycin, a nucleotide analogue, is a potent inhibitor of protein kinase C. J. Biol. Chem. 263:1988;1682-1692.
27. Lowry O.H., Rosebrough N.S., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
28. Masmoudi A., Labourdette G., Mersel M., Huang F.-L., Huang K., Vincendon G., Malviya A.N. Protein kinase C located in rat liver nuclei. J. Biol. Chem. 264:1989;1172-1179.
29. 1 exposure: phosphatidylinositol metabolism. Chem.-Biol. Interact. 98:1995;145-152.
30. 1 exposure: protein kinase C activity. Chem.-Biol. Interact. 100:1996;177-185.
31. Mukhtar H., DelTito B.J., Bickers D. Protection against 3-methylcholanthrene induced skin tumorigenesis in BALB/c mice by ellagic acid. Biochem. Biophys. Res. Commun. 119:1984;751-757.
32. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature. 308:1984;693-697.
33. Nishizuka Y. Studies and properties of protein kinase C. Science. 233:1986;305-312.
34. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implication for cellular regulation. Nature. 334:1988;661-665.
35. Nishizuka Y. The family of protein kinase C for signal transduction. J. Am. Med. Assoc. 262:1989;1826-1833.
36. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science. 253:1992;607-614.
37. 1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis. 5:1984;615-619.
38. Rillema J.A. Phospholipase C activity in normal rat mammary tissues and in DMBA induced rat mammary tumors. Proc. Soc. Exp. Biol. Med. 181:1986;450-453.
39. Schwartz G.K., Redwood S.M., Ohnuma T. Inhibition of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J. Natl. Cancer Inst. 82:1990;1753-1756.
40. H.F. Stich, W.D. Powrie, Naturally occurring phenolics as antimutagenic and anticarcinogenic agents, in: M. Friedman (Ed.), Nutritional and Toxicological Aspects of Food Safety, Plenum, New York, 1984, pp. 1-29.
41. Takai Y., Kishimoto A., Inoue M., Nishizuka Y. Studies on a cyclic nucleotide independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J. Biol. Chem. 252:1977;7603-7609.
42. Takai Y., Kishimoto A., Kikkawa U., Mori T., Nishizuka Y. Unsaturated diacylglycerol as a possible messenger for the activation of calcium activated, phospholipid dependent protein kinase system. Biochem. Biophys. Res. Commun. 91:1979;1218-1224.
43. Tamaoki T., Nakano H. Potent and specific inhibitors of protein kinase C of microbial origin. Biotechnology. 8:1990;732-735.
44. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:1986;397-402.
45. van Duuren B.L., Blazeji T., Goldschmidt B.M., Katz C., Melchionne S., Sivak A. Carcinogenic studies on mouse skin and inhibition of tumor promotion. J. Natl. Cancer Inst. 46:1971;1039-1044.
46. Vertosick F.T. Jr. The role of protein kinase C in the growth of humal gliomas: implications for therapy. Cancer J. 5:1992;328-331.
47. L.W. Wattenberg, Inhibition of carcinogenesis, in: A.C. Griffin, C.R. Shaw (Eds.), Carcinogens: Identification and Mechanism of Actions, Raven Press, New York, 1979, pp. 229-316.
48. Wattenberg L.W., Coccia J.B., Lam L.K.J. Inhibitory effects of phenolic compounds on benzo[a]pyrene induced neoplasia. Cancer Res. 40:1980;2820-2823.
49. Wattenberg L.W., Leong J.L. Inhibition of carcinogenic action of benzo[a]pyrene by flavones. Cancer Res. 30:1970;1922-1925.
50. Wollenweber E., Dietz V.H. Occurrence and distribution of free flavonoid aglycones in plants. Phytochemistry. 20:1981;869-932.